Example with LRC-TriCEPS applied to human primary T-cells
The LRC-TriCEPS applied to human primary T-cells Zellwerk GmbH, Germany and Dualsystems Biotech AG, Zurich joined forces and conducted successfully an entire LRC- TriCEPSTM experiment on primary T-cells. Positive control ligand (included in the kit): Anti-CD28 antibody the protein CD28 Ligand of interest: Anti-TCR2 α/β antibody Cells used: human primary T-cells Read all detail from…